<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors which belong to the nuclear receptor family </plain></SENT>
<SENT sid="1" pm="."><plain>We examined whether PPARalpha <z:chebi fb="4" ids="48705">agonists</z:chebi> and <z:chebi fb="0" ids="27881">resveratrol</z:chebi>, a <z:chebi fb="0" ids="26195">polyphenol</z:chebi> contained in grapes, protect the brain against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate whether <z:chebi fb="0" ids="27881">resveratrol</z:chebi> activates PPARs, we performed a cell-based transfection activity assay using luciferase reporter plasmid </plain></SENT>
<SENT sid="3" pm="."><plain>PPARalpha and PPARgamma were activated by <z:chebi fb="0" ids="27881">resveratrol</z:chebi> in primary cortical cultures and vascular endothelial cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="27881">Resveratrol</z:chebi> (20 mg/kg, 3 days) reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume by 36% at 24 h after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> in <z:mp ids='MP_0002169'>wild-type</z:mp> mice </plain></SENT>
<SENT sid="5" pm="."><plain>The PPARalpha <z:chebi fb="4" ids="48705">agonists</z:chebi> <z:chebi fb="0" ids="5001">fenofibrate</z:chebi> (30 mg/kg, 3 days) and Wy-14643 (30 mg/kg, days) exerted similar brain protection </plain></SENT>
<SENT sid="6" pm="."><plain>However, <z:chebi fb="0" ids="27881">resveratrol</z:chebi> and <z:chebi fb="0" ids="5001">fenofibrate</z:chebi> failed to protect the brain in PPARalpha knockout mice </plain></SENT>
<SENT sid="7" pm="."><plain>The data indicate that PPARalpha <z:chebi fb="4" ids="48705">agonists</z:chebi> protect the brain through PPARalpha </plain></SENT>
</text></document>